Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Akebia Therapeutics (AKBA) Inventory Average: 2019-2025

Historic Inventory Average for Akebia Therapeutics (AKBA) over the last 7 years, with Sep 2025 value amounting to $17.7 million.

  • Akebia Therapeutics' Inventory Average fell 20.32% to $17.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.7 million, marking a year-over-year decrease of 20.32%. This contributed to the annual value of $16.0 million for FY2024, which is 14.29% down from last year.
  • Akebia Therapeutics' Inventory Average amounted to $17.7 million in Q3 2025, which was down 2.99% from $18.2 million recorded in Q2 2025.
  • In the past 5 years, Akebia Therapeutics' Inventory Average ranged from a high of $52.9 million in Q1 2021 and a low of $17.1 million during Q4 2023.
  • Over the past 3 years, Akebia Therapeutics' median Inventory Average value was $19.7 million (recorded in 2023), while the average stood at $19.8 million.
  • In the last 5 years, Akebia Therapeutics' Inventory Average crashed by 62.88% in 2021 and then climbed by 19.58% in 2024.
  • Quarterly analysis of 5 years shows Akebia Therapeutics' Inventory Average stood at $35.2 million in 2021, then declined by 4.99% to $33.4 million in 2022, then tumbled by 48.91% to $17.1 million in 2023, then increased by 7.63% to $18.4 million in 2024, then declined by 20.32% to $17.7 million in 2025.
  • Its Inventory Average was $17.7 million in Q3 2025, compared to $18.2 million in Q2 2025 and $18.0 million in Q1 2025.